Mercè de Frías

931 total citations
17 papers, 734 citations indexed

About

Mercè de Frías is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Mercè de Frías has authored 17 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 11 papers in Molecular Biology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Mercè de Frías's work include Chronic Lymphocytic Leukemia Research (14 papers), Cell death mechanisms and regulation (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Mercè de Frías is often cited by papers focused on Chronic Lymphocytic Leukemia Research (14 papers), Cell death mechanisms and regulation (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Mercè de Frías collaborates with scholars based in Spain, France and United States. Mercè de Frías's co-authors include Joan Gil, Daniel Iglesias‐Serret, Ana M. Cosialls, Antonio F. Santidrián, Llorenç Coll-Mulet, Clara Campàs, Gabriel Pons, Montserrat Barragán, Alícia Domingo and Esther Castaño and has published in prestigious journals such as Blood, Clinical Cancer Research and Journal of Leukocyte Biology.

In The Last Decade

Mercè de Frías

17 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mercè de Frías Spain 13 511 237 184 103 94 17 734
Llorenç Coll-Mulet Spain 11 452 0.9× 263 1.1× 156 0.8× 90 0.9× 67 0.7× 12 663
Ana M. Cosialls Spain 18 601 1.2× 255 1.1× 178 1.0× 129 1.3× 92 1.0× 29 842
Eftihia Cocolakis Canada 12 898 1.8× 342 1.4× 81 0.4× 123 1.2× 69 0.7× 20 1.2k
Silvia L. Locatelli Italy 15 373 0.7× 146 0.6× 67 0.4× 144 1.4× 134 1.4× 42 616
Andrea Ghelli Luserna di Rorà Italy 13 513 1.0× 303 1.3× 63 0.3× 76 0.7× 73 0.8× 38 735
Luv Patel United States 12 459 0.9× 221 0.9× 65 0.4× 92 0.9× 68 0.7× 33 877
Iris Z. Uras Austria 14 481 0.9× 240 1.0× 136 0.7× 68 0.7× 68 0.7× 15 751
Kyoichiro Higashi Japan 11 399 0.8× 110 0.5× 112 0.6× 115 1.1× 65 0.7× 15 628
Matthew J. Saabye United States 8 267 0.5× 190 0.8× 85 0.5× 159 1.5× 56 0.6× 8 703
Stacey L. Hembruff United States 16 583 1.1× 351 1.5× 67 0.4× 99 1.0× 39 0.4× 23 890

Countries citing papers authored by Mercè de Frías

Since Specialization
Citations

This map shows the geographic impact of Mercè de Frías's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mercè de Frías with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mercè de Frías more than expected).

Fields of papers citing papers by Mercè de Frías

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mercè de Frías. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mercè de Frías. The network helps show where Mercè de Frías may publish in the future.

Co-authorship network of co-authors of Mercè de Frías

This figure shows the co-authorship network connecting the top 25 collaborators of Mercè de Frías. A scholar is included among the top collaborators of Mercè de Frías based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mercè de Frías. Mercè de Frías is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Montraveta, Arnau, Sílvia Xargay‐Torrent, Laia Rosich, et al.. (2015). Bcl-2highmantle cell lymphoma cells are sensitized to acadesine with ABT-199. Oncotarget. 6(25). 21159–21172. 10 indexed citations
2.
Montraveta, Arnau, Sílvia Xargay‐Torrent, Mònica López‐Guerra, et al.. (2014). Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20 monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma. Oncotarget. 5(3). 726–739. 16 indexed citations
3.
Neste, Eric Van Den, Bruno Cazin, Ann Janssens, et al.. (2012). Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study. Cancer Chemotherapy and Pharmacology. 71(3). 581–591. 44 indexed citations
4.
Coll-Mulet, Llorenç, Camila Rubio‐Patiño, Daniel Iglesias‐Serret, et al.. (2011). Analysis of apoptosis regulatory genes altered by histone deacetylase inhibitors in chronic lymphocytic leukemia cells. Epigenetics. 6(10). 1228–1235. 22 indexed citations
5.
Montraveta, Arnau, Mercè de Frías, Clara Campàs, et al.. (2011). Abstract A209: The nucleoside analogue acadesine exerts antitumoral activity and cooperates with anti-CD20 monoclonal antibodies in in vitro and in vivo models of mantle cell lymphoma.. Molecular Cancer Therapeutics. 10(11_Supplement). A209–A209. 2 indexed citations
6.
Mollinedo, Faustino, Janis de la Iglesia-Vicente, Consuelo Gajate, et al.. (2010). In vitro and In vivo Selective Antitumor Activity of Edelfosine against Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Involving Lipid Rafts. Clinical Cancer Research. 16(7). 2046–2054. 81 indexed citations
7.
Montraveta, Arnau, Mercè de Frías, Clara Campàs, et al.. (2010). The Nucleoside Analogue Acadesine Exerts Antitumoral Activity and Cooperates with Conventional Agents In In Vitro and In Vivo Models of Mantle Cell Lymphoma. Blood. 116(21). 3918–3918. 2 indexed citations
8.
Santidrián, Antonio F., Diana M. González‐Gironès, Daniel Iglesias‐Serret, et al.. (2010). AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells. Blood. 116(16). 3023–3032. 90 indexed citations
9.
Frías, Mercè de, Daniel Iglesias‐Serret, Ana M. Cosialls, et al.. (2009). Akt inhibitors induce apoptosis in chronic lymphocytic leukemia cells. Haematologica. 94(12). 1698–1707. 35 indexed citations
10.
Iglesias‐Serret, Daniel, Maria Piqué, Montserrat Barragán, et al.. (2009). Aspirin induces apoptosis in human leukemia cells independently of NF-κB and MAPKs through alteration of the Mcl-1/Noxa balance. APOPTOSIS. 15(2). 219–229. 30 indexed citations
11.
Santidrián, Antonio F., Ana M. Cosialls, Daniel Iglesias‐Serret, et al.. (2008). Multiplex ligation‐dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukaemia. British Journal of Haematology. 142(5). 793–801. 34 indexed citations
12.
Santidrián, Antonio F., Ana M. Cosialls, Daniel Iglesias‐Serret, et al.. (2007). Multiplex ligation-dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukemia.. Molecular Cancer Therapeutics. 6. 9 indexed citations
13.
Santidrián, Antonio F., Ana M. Cosialls, Daniel Iglesias‐Serret, et al.. (2007). The potential anticancer agent PK11195 induces apoptosis irrespective of p53 and ATM status in chronic lymphocytic leukemia cells. Haematologica. 92(12). 1631–1638. 25 indexed citations
14.
Iglesias‐Serret, Daniel, Mercè de Frías, Antonio F. Santidrián, et al.. (2006). Regulation of the proapoptotic BH3-only protein BIM by glucocorticoids, survival signals and proteasome in chronic lymphocytic leukemia cells. Leukemia. 21(2). 281–287. 43 indexed citations
15.
Campàs, Clara, Ana M. Cosialls, Montserrat Barragán, et al.. (2006). Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells. Experimental Hematology. 34(12). 1663–1669. 65 indexed citations
16.
Barragán, Montserrat, Mercè de Frías, Daniel Iglesias‐Serret, et al.. (2006). Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: role of protein kinase Cβ. Journal of Leukocyte Biology. 80(6). 1473–1479. 45 indexed citations
17.
Coll-Mulet, Llorenç, Daniel Iglesias‐Serret, Antonio F. Santidrián, et al.. (2006). MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells. Blood. 107(10). 4109–4114. 181 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Llorenç Coll-Mulet Breakdown of academic impact, for papers by Ana M. Cosialls Breakdown of academic impact, for papers by Eftihia Cocolakis Breakdown of academic impact, for papers by Silvia L. Locatelli Breakdown of academic impact, for papers by Andrea Ghelli Luserna di Rorà Breakdown of academic impact, for papers by Luv Patel Breakdown of academic impact, for papers by Iris Z. Uras Breakdown of academic impact, for papers by Kyoichiro Higashi Breakdown of academic impact, for papers by Matthew J. Saabye Breakdown of academic impact, for papers by Stacey L. Hembruff
Rankless by CCL
2026